More than 3,000 women under the age of 40 in France are diagnosed with breast cancer each year, and this number has been rising steadily. Unlike breast cancer in older women, which tends to be less aggressive, cancers in younger patients often present more severe forms. Nearly 70 percent of young patients receive chemotherapy, compared to just 30 percent of those over 60. This treatment can have serious side effects, including fatigue, hair loss, and changes in fertility. The reasons behind the increasing number of young women diagnosed with breast cancer are not fully understood. Researchers and medical professionals are exploring various factors, including lifestyle, genetics, and environmental influences. One key topic of discussion is early detection, as identifying breast cancer at an earlier stage can lead to more effective treatment and better outcomes. However, current screening guidelines in France typically recommend mammograms starting at age 50, which may leave younger women at higher risk of late diagnosis. In a recent episode of a health podcast, Margaux de Frouville and Alain Ducardonnet spoke with Florence Coussy, a gynecologist and oncologist at the Curie Institute in Paris. Coussy highlighted the challenges faced by younger patients and the need for more tailored approaches to diagnosis and treatment. She also emphasized the importance of increasing awareness and research into breast cancer in younger women. The conversation also included Clémence, a 30-year-old lawyer who recently completed four months of chemotherapy for a 6-millimeter tumor in her right breast. Clémence shared her personal experience, describing the physical and emotional toll of the treatment. Her story underscores the real-life impact of breast cancer on young women and the urgent need for better understanding and support for this group.